Abstract
Asthma is a common, chronic condition that is usually treated by the combination of inhaled steroids and β2 agonists on a when required basis. More recently, two further agents have been licensed for use: leukotriene receptor antagonists and very recently anti-IgE. This review describes a number of other possible treatment modalities. Some are well developed and already in Phase III clinical trials, others involve the use of drugs already on the market for other indications and a number are reasonably speculative.
Keywords: Asthma, treatment, anti-cytokine, statin, anti-IgE, toll-like receptors
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: New Therapeutic Interventions in Airway Inflammatory and Allergic Diseases
Volume: 5 Issue: 4
Author(s): M. Ennis
Affiliation:
Keywords: Asthma, treatment, anti-cytokine, statin, anti-IgE, toll-like receptors
Abstract: Asthma is a common, chronic condition that is usually treated by the combination of inhaled steroids and β2 agonists on a when required basis. More recently, two further agents have been licensed for use: leukotriene receptor antagonists and very recently anti-IgE. This review describes a number of other possible treatment modalities. Some are well developed and already in Phase III clinical trials, others involve the use of drugs already on the market for other indications and a number are reasonably speculative.
Export Options
About this article
Cite this article as:
Ennis M., New Therapeutic Interventions in Airway Inflammatory and Allergic Diseases, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2006; 5 (4) . https://dx.doi.org/10.2174/187152306778772874
DOI https://dx.doi.org/10.2174/187152306778772874 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry The Chemical Defensive System in the Pathobiology of Idiopathic Environment- Associated Diseases
Current Drug Metabolism Bioinformatics and Therapeutic Insights on Proteins in Royal Jelly
Current Proteomics Epitope Mapping and Identification of Amino Acids Critical for Rabbits IgG-Binding to Linear Epitopes on Buffalo beta-lactoglobulin
Protein & Peptide Letters The Toxicology of Chemokine Inhibition
Mini-Reviews in Medicinal Chemistry Pediatric Eosinophilic Esophagitis: Epidemiology, Diagnosis and Treatment
Current Pediatric Reviews Development Steps of Pharmacokinetics: A Perspective on Bioanalytical Methods and Bioequivalence
Current Clinical Pharmacology The Role of Platelets in Bone Remodeling
Inflammation & Allergy - Drug Targets (Discontinued) Cytokines in Human Breast Milk: Immunological Significance for Newborns
Current Nutrition & Food Science Developmental Current and Future Therapy for Severe Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Subject Index To Volume 2
Current Respiratory Medicine Reviews Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
Current Enzyme Inhibition Dietary Interventions for Atopic Disorders
Current Pharmaceutical Design <i>Barleria prionitis</i> L.: An Illustrative Traditional, Phytochemical and Pharmacological Review
The Natural Products Journal Oral Tolerance and TGF-β -Producing Cells
Inflammation & Allergy - Drug Targets (Discontinued) TRP Channels and Pain
Current Pharmaceutical Design Current Prospective of Aldose Reductase Inhibition in the Therapy of Allergic Airway Inflammation in Asthma
Current Molecular Medicine Current Prospective of Anti-IL-4, -IL-9, and -IL-13 Therapies in Allergic Disease
Recent Patents on Inflammation & Allergy Drug Discovery